Therefore, METTL3 and YTHDC1 mediated m6A modification made circSLCO1B3 more stable in ICC, which revealed that targeting m6A may be an effective strategy to inhibit circSLCO1B3 expression in ICC. The gene discussed is YTHDC1; the disease is intrahepatic cholangiocarcinoma.